Hormone Replacement Therapy Market Size

  • Report ID: 866
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Hormone Replacement Therapy Market Size

Hormone Replacement Therapy Market size was valued at USD 37.29 billion in 2024 and is expected to reach USD 98.63 billion by the end of 2037, expanding at around 7.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of hormone replacement therapy is evaluated at USD 39.62 billion.

The growth of the market is primarily attributed to the higher prevalence of chronic conditions such as hypogonadism in adult males across the globe. For instance, globally, hypogonadal males account for approximately 42% of men over the age of 45 and 55% of men in their 80s. Moreover, rising awareness regarding the post- menopausal issues among women is another major factor which is driving the growth of the market over the projected forecast period.

Global hormone replacement therapy market trends such as, skyrocketing investment by the government in the R&D of new medical technology and the growing prevalence of high blood pressure & hypertension are projected to influence the growth of the market positively over the forecast period. For instance, it is estimated that in every 4 adults, 1 of them aged between 20 to 45 suffers from high blood pressure worldwide. Additionally, in 2018, around 45% of the global population was projected to live with hypertension. Hence, all these factors are anticipated to propel the growth of the market over the forecast period.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 866
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of hormone replacement therapy is evaluated at USD 39.62 billion.

The hormone replacement therapy market size was valued at USD 37.29 billion in 2024 and is expected to reach USD 98.63 billion by the end of 2037, expanding at around 7.7% CAGR during the forecast period i.e., between 2025-2037. Higher number of women hitting menopause and growing cases of anxiety disorders will drive the market growth.

North America industry is anticipated to hold majority revenue share by 2037, propelled by significant growth in the geriatric population along with the significant presence of a well-structured healthcare infrastructure in the region.

The major players in the market include AbbVie Inc., Abbott Laboratories, Novo Nordisk A/S, Genentech, Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Merck KGaA, Mylan N.V., Bayer AG, Eli Lilly and Company.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample